2024. A prospective study of clinical profile of type 2 lepra-reaction, clinical responses to treatment with thalidomide and seroprevalence of HIV in reactional patients. Journal of Pakistan Association of Dermatologists. 34, 4 (Oct. 2024), 967–972. DOI:https://doi.org/10.66344/jpad.v34i4.2717.